Kodiak Sciences Inc (KOD): What's the Chance of Success for Zenkuda? [Yahoo! Finance]
Kodiak Sciences Inc (KOD)
Last kodiak sciences inc earnings: 11/12 05:30 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
Wainwright boosted its price target on Kodiak Sciences Inc (NASDAQ:KOD) to $58 from $38 and reiterated a Buy rating on the shares. The firm raised its price target after positive Phase 3 GLOW2 trial results for tarcocimab tedromer in diabetic retinopathy. Kodiak Sciences Inc (KOD): What's the Chance of Success for Zenkuda? Photo grabbed from Roivant Sciences website On March 26, Kodiak announced positive results from a Phase 3 trial of its experimental drug called Zenkuda (tarcocimab tedromer). Zenkuda is being evaluated as a treatment for patients with diabetic ?retinopathy. This is a diabetes-related eye complication that can result in a loss of vision. The company says that around 9.7 million people in the US live with diabetic retinopathy. In that study, 62.5% of patients treated with Zenkuda showed at least a two-step improvement in retinopathy severity. That compared with 3.3% of patients who received a sham treatment. With that, Zenkuda met the main goal of the trial.
Show less
Read more
Impact Snapshot
Event Time:
KOD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KOD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KOD alerts
High impacting Kodiak Sciences Inc news events
Weekly update
A roundup of the hottest topics
KOD
News
- Assessing Kodiak Sciences (KOD) Valuation After Recent Share Price Momentum And Conflicting Signals [Yahoo! Finance]Yahoo! Finance
- Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results [TheStreet.com]TheStreet.com
- Kodiak Sciences GAAP EPS of -$1.04 in-line [Seeking Alpha]Seeking Alpha
- Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial ResultsPR Newswire
KOD
Earnings
- 3/31/26 - Miss
KOD
Sec Filings
- 4/27/26 - Form SCHEDULE
- 4/23/26 - Form ARS
- 4/22/26 - Form DEFA14A
- KOD's page on the SEC website